SECARE expects double-digit revenue growth while holding margins stable, according to the company's outlook reported by TradingView — a projection delivered against the backdrop of a distributor merger now under way in the United States.

The outlook rests on three disclosed elements: a growth rate in the double digits, margins the company expects to hold steady, and a normalization of Amazon's channel dynamics that SECARE anticipates as the U.S. merger advances. Each carries distinct implications for gross margin, channel power and customer economics — and each warrants separating what is measured from what is asserted.

The growth claim. Double-digit growth is a forward projection, not a reported result. For a distributor, growth at that pace can come from volume, price mix or acquisition; the source does not break down which. What it does signal is management confidence that demand in SECARE's verticals supports top-line expansion without forced discounting — the mechanism that typically erodes distributor gross margin when growth is bought rather than earned.

The margin claim. Stable margins, if achieved alongside double-digit growth, would indicate pricing discipline and controlled input costs — inventory bought at the right price and turned at a rate that avoids markdown exposure. Distributors that grow revenue while gross margin holds flat are effectively expanding operating leverage: fixed costs spread over a larger revenue base. The risk case is that growth requires working-capital build — more inventory on the balance sheet, slower turns — which would pressure cash conversion even if reported margin percentages hold. The source does not disclose inventory metrics, so that question remains open.

The Amazon factor. The expectation of Amazon "normalization" is the most analytically interesting element. The word implies a prior period of disruption — pricing pressure, share shift or channel conflict that compressed distributor economics in categories Amazon entered. Normalization suggests SECARE believes that pressure has peaked and is now receding, allowing conventional wholesale pricing structures and customer relationships to reassert themselves. That claim deserves interrogation. Platform and marketplace dynamics rarely reverse on their own; they stabilize when suppliers enforce channel pricing discipline, when distributors differentiate on service and availability, or when platform economics force retrenchment in low-margin categories. Which of these forces SECARE is counting on is not disclosed.

The merger variable. The U.S. distributor merger frames all three projections. Consolidation among distributors typically shifts channel power in one of two directions: toward the combined entity, which can extract better supplier terms and consolidate purchasing to lift gross margin; or toward suppliers, if the merged distributor's scale lets it prioritize competing lines. For SECARE, a merged U.S. distributor peer could mean a stronger competitor in overlapping verticals, or an integration disruption window that creates share-taking opportunities. Double-digit growth in that environment implies SECARE expects to compete through the transition rather than cede ground.

The merger also bears directly on the Amazon question. Consolidated distributors with denser fulfillment networks and unified pricing can match platform delivery economics more credibly than fragmented independents — one plausible mechanism behind a normalization thesis.

What to watch. The projection leaves measurable checkpoints for the coming quarters: whether revenue growth prints at or above the double-digit threshold; whether gross margin percentage holds within its historical band as growth accelerates; and whether evidence emerges that Amazon's pricing aggression in SECARE's categories has actually moderated rather than merely paused. The merger's closing conditions, integration timeline and any divestiture requirements in the United States will shape the competitive backdrop.

SECARE's outlook, as reported, pairs an assertive growth target with a conservative margin assumption and a recovering-channel thesis. If all three hold, the company enters the post-merger U.S. market with leverage; if the Amazon normalization proves premature, the stable-margin commitment will be the first assumption tested.